Zovirax: Effective Antiviral Treatment for Herpes Infections
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.25 | $44.72 (0%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $89.44 $79.98 (11%) | 🛒 Add to cart |
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.77 | $46.44 (0%) | 🛒 Add to cart |
| 90 | $0.70 | $69.66 $62.78 (10%) | 🛒 Add to cart |
| 120 | $0.66 | $92.88 $79.12 (15%) | 🛒 Add to cart |
| 180 | $0.62 | $139.32 $110.94 (20%) | 🛒 Add to cart |
| 270 | $0.59 | $208.98 $159.10 (24%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $278.64 $208.12 (25%) | 🛒 Add to cart |
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.52 | $75.68 (0%) | 🛒 Add to cart |
| 60 | $1.91 | $151.36 $114.38 (24%) | 🛒 Add to cart |
| 90 | $1.70 | $227.04 $153.08 (33%) | 🛒 Add to cart |
| 120 | $1.61 | $302.72 $193.50 (36%) | 🛒 Add to cart |
| 180 | $1.50 | $454.08 $270.90 (40%) | 🛒 Add to cart |
| 270 | $1.44 | $681.12 $387.86 (43%) | 🛒 Add to cart |
| 360 | $1.40
Best per pill | $908.16 $504.82 (44%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Zovirax (acyclovir) is a pioneering antiviral medication specifically formulated to manage infections caused by the herpes simplex virus (HSV) and varicella-zoster virus (VZV). As a nucleoside analogue DNA polymerase inhibitor, it works by inhibiting viral replication, thereby reducing the severity and duration of outbreaks. This prescription medication is available in multiple formulations, including oral tablets, capsules, suspension, topical cream, and intravenous injection, allowing for tailored treatment approaches based on clinical presentation and patient needs. Trusted by healthcare professionals for decades, Zovirax represents a cornerstone in antiviral therapy, offering both therapeutic and suppressive benefits for appropriate patient populations.
Features
- Contains acyclovir as the active pharmaceutical ingredient
- Available in multiple formulations: 200mg, 400mg, and 800mg oral tablets; 200mg capsules; 5% topical cream; 200mg/5mL oral suspension; and intravenous injection
- Manufactured under strict pharmaceutical quality control standards
- Requires prescription for all formulations
- Specific storage requirements: room temperature (15-25°C) for oral and topical forms; refrigerated suspension
- Bioavailability varies by formulation: approximately 15-30% for oral administration
Benefits
- Significantly reduces healing time for initial and recurrent herpes outbreaks
- Decreases the duration of viral shedding and pain associated with lesions
- Helps prevent new lesion formation when used early in prodromal phase
- Can be used chronically for suppression of recurrent genital herpes
- Reduces risk of transmission to partners when used as suppressive therapy
- Effective management of herpes zoster (shingles) to minimize complications
Common use
Zovirax is primarily indicated for the treatment of infections caused by herpes viruses. This includes genital herpes (both initial episodes and recurrent infections), herpes labialis (cold sores), herpes zoster (shingles), and chickenpox in immunocompromised patients. Additionally, it is used for prophylaxis against herpes infections in immunocompromised patients, such as those undergoing chemotherapy or organ transplantation. The medication may also be prescribed off-label for other herpesvirus infections under specialist supervision, following comprehensive viral diagnosis and risk-benefit assessment.
Dosage and direction
Dosage varies significantly based on indication, patient immune status, and formulation:
Oral tablets/capsules:
- Genital herpes (initial): 200mg every 4 hours (5 times daily) for 10 days
- Recurrent genital herpes: 200mg every 4 hours (5 times daily) for 5 days
- Chronic suppression: 400mg twice daily or 200mg three times daily
- Herpes zoster: 800mg every 4 hours (5 times daily) for 7-10 days
- Chickenpox: 20mg/kg (max 800mg) four times daily for 5 days
Topical cream:
- Apply to affected area every 3 hours (6 times daily) for 7 days
Intravenous:
- 5-10mg/kg every 8 hours for 7 days (dose adjusted for renal function)
All doses should be taken with adequate fluid intake. Treatment should be initiated at the earliest sign or symptom of recurrence for optimal efficacy. Dosage adjustments are required for patients with renal impairment.
Precautions
Patients should maintain adequate hydration during treatment to prevent crystalluria. Renal function should be monitored during intravenous therapy, particularly in elderly patients or those with pre-existing renal impairment. Use with caution in patients with neurological abnormalities, serious hepatic or electrolyte abnormalities, or substantial hypoxia. Topical application should avoid contact with eyes, and application to mucous membranes should be performed with medical guidance. Pregnancy category B: use only if clearly needed after risk-benefit assessment. Breastfeeding considerations: acyclovir concentrates in breast milk—consult healthcare provider.
Contraindications
Zovirax is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. The intravenous formulation is contraindicated in patients with history of serious hypersensitivity reactions to acyclovir, including anaphylaxis. Additional contraindications include patients with severe renal impairment (creatinine clearance <10 mL/min) not undergoing hemodialysis, and those with underlying neurological conditions that might be exacerbated by neurotoxic effects observed at high intravenous doses.
Possible side effect
Common side effects (≥1%) include nausea, vomiting, diarrhea, headache, and dizziness. Topical application may cause mild pain, burning, or stinging at application site. Less frequent adverse reactions include fatigue, skin rash, and musculoskeletal pain. Rare but serious side effects require immediate medical attention: neurological symptoms (agitation, confusion, hallucinations, seizures), signs of renal impairment (decreased urination, swelling), hepatitis symptoms (jaundice, dark urine), or severe skin reactions. Intravenous administration carries additional risks of inflammation at injection site, and in overdose situations, renal failure and neurological toxicity.
Drug interaction
Probenecid significantly increases acyclovir plasma concentrations by reducing renal clearance. Concurrent use with other nephrotoxic drugs (aminoglycosides, cyclosporine, NSAIDs, vancomycin) may increase risk of renal dysfunction. Zidovudine may cause increased drowsiness or lethargy when combined with acyclovir. Immunosuppressants may have enhanced effects when combined with antiviral therapy. Monitoring is recommended when administered with medications that compete for renal tubular secretion. No clinically significant interactions with oral contraceptives have been documented.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain the regular dosing schedule. For twice-daily dosing, if missed and remembered within 6 hours of scheduled time, take immediately; if beyond 6 hours, skip and resume normal schedule. For more frequent dosing regimens, consult prescribing physician for specific guidance based on treatment indication and timing considerations.
Overdose
Overdose symptoms may include agitation, coma, seizures, lethargy, and renal impairment. In cases of oral overdose, gastric lavage may be considered if presented early. Maintain adequate hydration to promote renal elimination. Hemodialysis significantly enhances acyclovir removal (approximately 60% reduction in plasma concentrations during 4-hour dialysis). Management should include supportive care and monitoring of renal function through serum creatinine and urine output. Neurological symptoms should be managed symptomatically. Contact poison control center immediately for specific management recommendations.
Storage
Store at room temperature (15-25°C or 59-77°F) in original container, protected from light and moisture. Keep tightly closed. Do not freeze. Oral suspension should be stored in refrigerator (2-8°C or 36-46°F) and discarded after 28 days. Keep all medications out of reach of children and pets. Do not use beyond expiration date printed on packaging. Do not transfer between containers as this may affect stability and protection from environmental factors.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual treatment decisions must be made by qualified healthcare professionals based on specific clinical circumstances. Always follow the prescribed dosage and instructions provided by your physician. Report any adverse effects to your healthcare provider promptly. Not all possible uses, interactions, or precautions are listed here. Full prescribing information is available from the manufacturer or regulatory authorities.
Reviews
Clinical studies demonstrate Zovirax reduces healing time by approximately 2 days in recurrent genital herpes and 1-2 days in herpes labialis compared to placebo. Meta-analyses show suppressive therapy reduces recurrence frequency by 70-80% in patients with frequent genital herpes outbreaks. Patient-reported outcomes indicate significant improvement in quality of life measures, particularly reduction in pain and emotional distress associated with recurrent outbreaks. Healthcare professionals consistently rate Zovirax as a well-tolerated and effective first-line treatment for herpes virus infections when initiated appropriately.